[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100569119":3},{"organization":4,"outcomesModule":7,"designInfo":14,"detailedDescription":17,"studyPopulation":18,"armGroups":19,"interventions":13,"overallOfficials":13,"centralContacts":23,"locations":29,"responsibleParty":49,"collaborators":13,"id":51,"slug":13,"hasResults":52,"nctId":53,"briefTitle":54,"officialTitle":54,"acronym":13,"eligibilityCriteria":55,"healthyVolunteers":52,"sex":56,"minAge":57,"maxAge":13,"enrollmentInfo":58,"targetDuration":13,"studyType":61,"phases":13,"briefSummary":62,"conditions":63,"keywords":66,"overallStatus":32,"whyStopped":13,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":80},{"fullName":5,"class":6},"Devyser Inc.","INDUSTRY",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":13},[9],{"measure":10,"description":11,"timeFrame":12},"Fetal RhD determination from maternal whole blood","Collected samples will be used for future development of non-invasive prenatal test to determine fetal RhD status from maternal whole blood","18 months",null,{"allocation":13,"interventionModel":13,"interventionModelDescription":13,"primaryPurpose":13,"observationalModel":15,"timePerspective":16,"maskingInfo":13},"COHORT","PROSPECTIVE","This is a prospective multi-center blood collection study. Women 18 years of age or older with a viable singleton pregnancy between12 weeks and 28 weeks gestation will be enrolled.\n\nWhole blood samples will be collected from each enrolled patient. Maternal specimens will be processed to plasma and stored for future testing with non-invasive prenatal tests to identify fetal Rh status.\n\nBaby RhD blood type status will be recorded after delivery. All obstetric clinical management will take place per standard clinic practices and procedures and will not be altered by participation in the study.","Pregnant women who are RhD negative and between 12 and 28 weeks gestation.",[20],{"label":21,"type":13,"description":22,"interventionNames":13},"Pregnant women","Pregnant women who are RhD negative and between 12 and 28 weeks gestation",[24],{"name":25,"role":26,"phone":27,"phoneExt":13,"email":28},"Tasha Kalista Sr. Director, Clinical Affairs","CONTACT","8135508310","tasha.kalista@devyser.us.com",[30],{"facility":31,"status":32,"city":33,"state":34,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"Ochsner Health","RECRUITING","New Orleans","Louisiana","70115","United States","US",{"type":39,"coordinates":40},"Point",[41,42],-90.07507,29.95465,{"lat":42,"lon":41},[45],{"name":46,"role":26,"phone":47,"phoneExt":13,"email":48},"Paige Delaune","504-894-2859","paige.delaune@ochsner.org",{"type":50,"investigatorFullName":13,"investigatorTitle":13,"investigatorAffiliation":13,"oldNameTitle":13,"oldOrganization":13},"SPONSOR","100569119",false,"NCT06690099","Prospective Collection of Whole Blood Specimens From RhD Negative Pregnant Women","Inclusion Criteria:\n\n1. Willing and able to provide written informed consent\n2. 18 years of age or older at enrollment\n3. Women with a viable pregnancy (with documented fetal heartbeat) between 12 weeks, 0 days and 28 weeks, 0 days gestational age\n4. Women with RhD negative antigen status by serology\n5. Willing to provide neonatal ABO and RhD genotyping status\n\nExclusion Criteria:\n\n1\\. Women with multiple gestation pregnancy","FEMALE","18 Years",{"count":59,"type":60},500,"ESTIMATED","OBSERVATIONAL","The purpose of this research is to collect blood samples and data from pregnant women who are Rh negative. The blood will be used for the future research and the development of non-invasive prenatal tests to identify Rh blood type status of the baby during pregnancy.",[64,65],"Rhesus D Genotype","Pregnancy",[67,68,69,70],"RhD negative","fetal DNA","cell free fetal DNA","Fetal RhD genotype","2025-05-28",{"date":73,"type":74},"2025-06-03","ACTUAL",{"date":76,"type":74},"2025-04-07",{"date":78,"type":60},"2026-12",{"name":5,"class":6},1]